Corticosterone pattern-dependent glucocorticoid receptor binding and transcriptional regulation within the liver. 2021

Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol, United Kingdom.

Ultradian glucocorticoid rhythms are highly conserved across mammalian species, however, their functional significance is not yet fully understood. Here we demonstrate that pulsatile corticosterone replacement in adrenalectomised rats induces a dynamic pattern of glucocorticoid receptor (GR) binding at ~3,000 genomic sites in liver at the pulse peak, subsequently not found during the pulse nadir. In contrast, constant corticosterone replacement induced prolonged binding at the majority of these sites. Additionally, each pattern further induced markedly different transcriptional responses. During pulsatile treatment, intragenic occupancy by active RNA polymerase II exhibited pulsatile dynamics with transient changes in enrichment, either decreased or increased depending on the gene, which mostly returned to baseline during the inter-pulse interval. In contrast, constant corticosterone exposure induced prolonged effects on RNA polymerase II occupancy at the majority of gene targets, thus acting as a sustained regulatory signal for both transactivation and repression of glucocorticoid target genes. The nett effect of these differences were consequently seen in the liver transcriptome as RNA-seq analysis indicated that despite the same overall amount of corticosterone infused, twice the number of transcripts were regulated by constant corticosterone infusion, when compared to pulsatile. Target genes that were found to be differentially regulated in a pattern-dependent manner were enriched in functional pathways including carbohydrate, cholesterol, glucose and fat metabolism as well as inflammation, suggesting a functional role for dysregulated glucocorticoid rhythms in the development of metabolic dysfunction.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010507 Periodicity The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian). Cyclicity,Rhythmicity,Biological Rhythms,Bioperiodicity,Biorhythms,Biological Rhythm,Bioperiodicities,Biorhythm,Cyclicities,Periodicities,Rhythm, Biological,Rhythmicities,Rhythms, Biological
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012319 RNA Polymerase II A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. DNA-Dependent RNA Polymerase II,RNA Pol II,RNA Polymerase B,DNA Dependent RNA Polymerase II
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
March 1995, Molecular and cellular endocrinology,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
April 1989, Journal of steroid biochemistry,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
May 2015, BMC veterinary research,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
February 1989, Archives of biochemistry and biophysics,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
July 2021, Proceedings of the National Academy of Sciences of the United States of America,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
August 1986, Proceedings of the National Academy of Sciences of the United States of America,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
April 2013, BMC veterinary research,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
July 1994, Brain research,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
June 2007, PLoS genetics,
Benjamin P Flynn, and Matthew T Birnie, and Yvonne M Kershaw, and Audrys G Pauza, and Sohyoung Kim, and Songjoon Baek, and Mark F Rogers, and Alex R Paterson, and Diana A Stavreva, and David Murphy, and Gordon L Hager, and Stafford L Lightman, and Becky L Conway-Campbell
June 2005, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!